LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas-Reference-Cited by-同舟云学术

LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas

Published:2018-05-16 Issue:1 Volume:82 Page:139-147
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Rusz Orsolya,Papp Orsolya,Vízkeleti Laura,Molnár Béla Ákos,Bende Kristóf Csaba,Lotz Gábor,Ács Balázs,Kahán Zsuzsanna,Székely Tamás,Báthori Ágnes,Szundi Csilla,Kulka Janina,Szállási Zoltán,Tőkés Anna-Mária

Funder

Breast Cancer Research Foundation

The Research and Technology Innovation Fund

New National Excellence Program

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-018-3602-z/fulltext.html

Reference23 articles.

1. Gralow JR (2005) Optimizing the treatment of metastatic breast cancer. Breast Cancer Res Treat 89(Suppl 1):S9–S15. https://doi.org/10.1007/s10549-005-0143-z

2. Haibe-Kains B, Desmedt C, Di Leo A, Azambuja E, Larsimont D, Selleslags J, Delaloge S, Duhem C, Kains JP, Carly B, Maerevoet M, Vindevoghel A, Rouas G, Lallemand F, Durbecq V, Cardoso F, Salgado R, Rovere R, Bontempi G, Michiels S, Buyse M, Nogaret JM, Qi Y, Symmans F, Pusztai L, D’Hondt V, Piccart-Gebhart M, Sotiriou C (2013) Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients. Genom Data 1:7–10. https://doi.org/10.1016/j.gdata.2013.09.001

3. Desmedt C, Di Leo A, de Azambuja E, Larsimont D, Haibe-Kains B, Selleslags J, Delaloge S, Duhem C, Kains JP, Carly B, Maerevoet M, Vindevoghel A, Rouas G, Lallemand F, Durbecq V, Cardoso F, Salgado R, Rovere R, Bontempi G, Michiels S, Buyse M, Nogaret JM, Qi Y, Symmans F, Pusztai L, D’Hondt V, Piccart-Gebhart M, Sotiriou C (2011) Multifactorial approach to predicting resistance to anthracyclines. J Clin Oncol 29:1578–1586. https://doi.org/10.1200/JCO.2010.31.2231

4. Mukherjee A, Shehata M, Moseley P, Rakha E, Ellis I, Chan S (2010) Topo2alpha protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer. Br J Cancer 103:1794–1800. https://doi.org/10.1038/sj.bjc.6605960

5. Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, Desmedt C, Sotiriou C, Szallasi Z, Iglehart JD, Richardson AL, Wang ZC (2010) Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med 16:214–218. https://doi.org/10.1038/nm.2090

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer;BioMed Research International;2022-11-30